Search

everythinglearnresearchcommunity

for

Search:↓

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Alopecia areata is more common in young Black African males, with rare other health issues.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Scalp psoriasis treatments like strong corticosteroids and vitamin D3 analogues are effective, especially when combined.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.